Literature DB >> 21501875

ECT efficacy and treatment course: a systematic review and meta-analysis of twice vs thrice weekly schedules.

Fiona Charlson1, Dan Siskind, Suhail A R Doi, Emily McCallum, Annette Broome, David C Lie.   

Abstract

BACKGROUND: Electroconvulsive therapy (ECT) guidelines, across various regulatory bodies, lack consensus as to the optimal frequency of treatment for individual patients. Some authors postulate that twice weekly ECT may have a similar efficacy to thrice weekly, and may have a lower risk of adverse cognitive outcomes. We did a systematic review and a meta-analysis to assess the strength of associations between ECT frequency and depression scores, duration of treatment, number of ECTs, and remission rates.
METHODS: We searched on Medline, EMBASE, CINAHL and the Cochrane Central Register of Controlled Trials (to December 2009), and searched reports to identify comparative studies of frequency of ECT. We did both random-effects (RE) and quality effect (QE) meta-analyses to determine the risk of various outcomes associated with lesser frequency as compared to the thrice weekly frequency.
RESULTS: We analysed 8 datasets (7 articles), including 214 subjects. Twice-weekly frequency of ECT was associated with a similar change in depression score (QE model SMD -0.11 [-0.55-0.33] and RE model SMD -0.17 [-0.77-0.43]) as compared to thrice weekly ECT. The number of real ECT's trended towards fewer in the twice weekly group. There was a statistically significant longer duration of treatment with a twice weekly protocol (QE model 6.48 days [4.99-7.97] and RE model 4.78 days [0.74-8.82]). There was a statistically significant greater efficacy for thrice weekly ECT compared to once weekly ECT (QE model SMD 1.25 [-0.62-1.9] and RE model SMD 1.31 [0.6-2.02]).
CONCLUSIONS: Twice weekly ECT is associated with similar efficacy to thrice weekly ECT, may require fewer treatments and may be associated with longer treatment duration when compared to thrice weekly. These epidemiological observations support the routine use of twice weekly ECT in acute courses, though choice of frequency should take into account individual patient factors. These observations have implications for resource utilisation e.g. costs of duration of admission vs cost of provision of ECT, as well as issues of access to inpatient beds and anaesthetist time. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21501875     DOI: 10.1016/j.jad.2011.03.039

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

Review 1.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.

Authors:  Roumen V Milev; Peter Giacobbe; Sidney H Kennedy; Daniel M Blumberger; Zafiris J Daskalakis; Jonathan Downar; Mandana Modirrousta; Simon Patry; Fidel Vila-Rodriguez; Raymond W Lam; Glenda M MacQueen; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

2.  Functional connectivity underpinnings of electroconvulsive therapy-induced memory impairments in patients with depression.

Authors:  Danhong Wang; Yanghua Tian; Meiling Li; Louisa Dahmani; Qiang Wei; Tongjian Bai; Franziska Galiè; Jianxun Ren; Rai Khalid Farooq; Kangcheng Wang; Jie Lu; Kai Wang; Hesheng Liu
Journal:  Neuropsychopharmacology       Date:  2020-05-20       Impact factor: 7.853

Review 3.  Auditory verbal hallucinations in schizophrenia: current perspectives in brain stimulation treatments.

Authors:  Clément Nathou; Olivier Etard; Sonia Dollfus
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-24       Impact factor: 2.570

4.  Vagus Nerve Stimulation For Treatment Resistant Depression: Case Series Of Six Patients - Retrospective Efficacy And Safety Observation After One Year Follow Up.

Authors:  Krzysztof Kucia; Wojciech Merk; Krzysztof Zapalowicz; Tomasz Medrala
Journal:  Neuropsychiatr Dis Treat       Date:  2019-11-25       Impact factor: 2.570

5.  A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).

Authors:  Virginie Moulier; Mohamed Wassim Krir; Marine Dalmont; Olivier Guillin; Maud Rothärmel
Journal:  Trials       Date:  2021-04-15       Impact factor: 2.279

6.  Effects of electroconvulsive therapy on cognitive functioning in patients with depression: protocol for a systematic review and meta-analysis.

Authors:  Carolina Oremus; Mark Oremus; Heather McNeely; Bruno Losier; Melissa Parlar; Matthew King; Gary Hasey; Gagan Fervaha; Allyson C Graham; Caitlin Gregory; Lindsay Hanford; Anthony Nazarov; Maria Restivo; Erica Tatham; Wanda Truong; Geoffrey B C Hall; Ruth Lanius; Margaret McKinnon
Journal:  BMJ Open       Date:  2015-03-11       Impact factor: 2.692

Review 7.  Vagus Nerve Stimulation (VNS) and Other Augmentation Strategies for Therapy-Resistant Depression (TRD): Review of the Evidence and Clinical Advice for Use.

Authors:  Helge H O Müller; Sebastian Moeller; Caroline Lücke; Alexandra P Lam; Niclas Braun; Alexandra Philipsen
Journal:  Front Neurosci       Date:  2018-04-10       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.